{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-02-11T12:44:47.346844+00:00",
  "news": [
    {
      "title": "1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQMzgtRWlRMUJ3TnhTcmJRQ2FQN3RXTnhzNER2WlVpVThUT2I1M0hKRWFYa21Pb1ZrUEZFek5adjVVeU5XdGl5dTZ1NFpnR0dXZ2hwSVJveVJBQzJXTkZoT2l0d0hNc0FXU1NmUGpTY0tMbjB4NjF6dnJyckhlSS0xVUNkRWhfSGNRV2kzbGpyWGgtVmRnNEFN?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxQMzgtRWlRMUJ3TnhTcmJRQ2FQN3RXTnhzNER2WlVpVThUT2I1M0hKRWFYa21Pb1ZrUEZFek5adjVVeU5XdGl5dTZ1NFpnR0dXZ2hwSVJveVJBQzJXTkZoT2l0d0hNc0FXU1NmUGpTY0tMbjB4NjF6dnJyckhlSS0xVUNkRWhfSGNRV2kzbGpyWGgtVmRnNEFN?oc=5\" target=\"_blank\">1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2026-02-10T18:15:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Vertex Expands Beyond Cystic Fibrosis With WuXi Autoimmune T Cell Deal - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxQLUZuemlPcUFVanRyVWFYNnFqRVcwejhqM2kwQzE0dExGRGFpTXRILXNwZ1ZTaGRxRUZJYWVZQ2s1ZmdtU1doQVViaHNYd0hveG03REd6UnVyM0tsSnhLcmtWOW9FbllGVDBQdFB6bml1N1V3VkV0MFNfYVRIaTROWnFHTHBBY2tHLXZMM1NxaFNFeHlqbU5HMms1RVZObXl2bFpqSC0zSGlZYnFpVkZIWWJ3S3F1d043QVRRVVJLQWZaX0J6TS1BMUlSZmFrcS1ZLVdqNVNYQzhWQ2pfSGthQ0FDZkdLZ2JxcWI2MQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxQLUZuemlPcUFVanRyVWFYNnFqRVcwejhqM2kwQzE0dExGRGFpTXRILXNwZ1ZTaGRxRUZJYWVZQ2s1ZmdtU1doQVViaHNYd0hveG03REd6UnVyM0tsSnhLcmtWOW9FbllGVDBQdFB6bml1N1V3VkV0MFNfYVRIaTROWnFHTHBBY2tHLXZMM1NxaFNFeHlqbU5HMms1RVZObXl2bFpqSC0zSGlZYnFpVkZIWWJ3S3F1d043QVRRVVJLQWZaX0J6TS1BMUlSZmFrcS1ZLVdqNVNYQzhWQ2pfSGthQ0FDZkdLZ2JxcWI2MQ?oc=5\" target=\"_blank\">Vertex Expands Beyond Cystic Fibrosis With WuXi Autoimmune T Cell Deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-02-11T11:55:04+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Momentum - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOY0ZVRkJkc0U1a0Z0RXU1ZzVLTTFRN2JBNldyVmNmd0JTZ1lmRXMtZFNwazUzbGNwZGlxWGpJZFZPSlVrejRJWEg1TXpzaHE1QUNQSXRqVUl0Y0lRWEJqUmhobjk0cUZUcWdGMlVMV1VqVXA3SjZrMmM4VXhzeWRRVFJzMDlYRWRBZjlHbjRvQ09ydw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxOY0ZVRkJkc0U1a0Z0RXU1ZzVLTTFRN2JBNldyVmNmd0JTZ1lmRXMtZFNwazUzbGNwZGlxWGpJZFZPSlVrejRJWEg1TXpzaHE1QUNQSXRqVUl0Y0lRWEJqUmhobjk0cUZUcWdGMlVMV1VqVXA3SjZrMmM4VXhzeWRRVFJzMDlYRWRBZjlHbjRvQ09ydw?oc=5\" target=\"_blank\">A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Momentum</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-02-10T06:06:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Stocks Generating Improved Relative Strength: Vertex Pharmaceuticals - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOeEpFWmI3b3JhaTdvZzFTdnFhZ3NqTmZyUHQ1SDNXc0gyZkJLNnBFQkc1RVVpRnIxWG1wdXFxVkd4TGFnZ0RZR2Vuc29FQkF0T3psZm1yUjZjQ0VDWWU4RGtTLXRhbmJXa0VGRDFTZjBrbjN4UWtoQ1JiWWROQjU0elJ6OWFYeHZMZ2pkdHpDUUI1X3p4STZmYXJZdUxNRkZHbWhaNktwQkdEc1FwV0lzag?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxOeEpFWmI3b3JhaTdvZzFTdnFhZ3NqTmZyUHQ1SDNXc0gyZkJLNnBFQkc1RVVpRnIxWG1wdXFxVkd4TGFnZ0RZR2Vuc29FQkF0T3psZm1yUjZjQ0VDWWU4RGtTLXRhbmJXa0VGRDFTZjBrbjN4UWtoQ1JiWWROQjU0elJ6OWFYeHZMZ2pkdHpDUUI1X3p4STZmYXJZdUxNRkZHbWhaNktwQkdEc1FwV0lzag?oc=5\" target=\"_blank\">Stocks Generating Improved Relative Strength: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2026-02-09T08:00:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxOR1RaTTJCd0d2cThhbVpFazZlVjIzRkpCLVpUVUIxOE8tMlBvUFFLTGJST0hDNDJqMjUzdWtEOWgtbEwwU0tpWnJjcmI5RHdKa1A2RG5ILW5Ucy1zRVJfWmpBcm5tUkNPQW1ud0xsVHpJRFM0RmpfVVJXMDdvWFdCbFJTYVdhSjZxLVNiNWJTdzhVTndXS1ItRnB6Q2xIQmhpUlZjQlVYZUwxX1BnWGh0RWowS2JCTUhsVU0xbk5NRkVMYTZpRDdfQldyX0QtQzlSTjJRcw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOR1RaTTJCd0d2cThhbVpFazZlVjIzRkpCLVpUVUIxOE8tMlBvUFFLTGJST0hDNDJqMjUzdWtEOWgtbEwwU0tpWnJjcmI5RHdKa1A2RG5ILW5Ucy1zRVJfWmpBcm5tUkNPQW1ud0xsVHpJRFM0RmpfVVJXMDdvWFdCbFJTYVdhSjZxLVNiNWJTdzhVTndXS1ItRnB6Q2xIQmhpUlZjQlVYZUwxX1BnWGh0RWowS2JCTUhsVU0xbk5NRkVMYTZpRDdfQldyX0QtQzlSTjJRcw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2026-02-11T03:58:56+00:00",
      "source": "The Globe and Mail"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Receives FDA Orphan Drug Status fo - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdjdnMWx4Sk5iMjFLUGJ2UEFubXJ0YjBNSU5VZ0R6dHVJQ3BHNkFHT0VReWJicF94V0tzNmZUam41M25XZVdMWHZwdTJ1cDNIb09pZlpIZ1hGRndkblBPMHh3eTJjeDV6OVFtdHRoWVBiVFpEdUd1b1JJd1BubFozaXlOSG5QTExWdGxBMkhydUwtYnY3YXVJd2g1cnA4N2VJRWZQVUZhOXFFb3JORFJuVXJPV2staDQ0R1kwRTZmY3Z1Tk5TSV85TTlR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPdjdnMWx4Sk5iMjFLUGJ2UEFubXJ0YjBNSU5VZ0R6dHVJQ3BHNkFHT0VReWJicF94V0tzNmZUam41M25XZVdMWHZwdTJ1cDNIb09pZlpIZ1hGRndkblBPMHh3eTJjeDV6OVFtdHRoWVBiVFpEdUd1b1JJd1BubFozaXlOSG5QTExWdGxBMkhydUwtYnY3YXVJd2g1cnA4N2VJRWZQVUZhOXFFb3JORFJuVXJPV2staDQ0R1kwRTZmY3Z1Tk5TSV85TTlR?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Receives FDA Orphan Drug Status fo</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2026-02-10T23:55:24+00:00",
      "source": "GuruFocus"
    },
    {
      "title": "Should You Buy Vertex Pharmaceuticals Before Feb. 12? - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOcFNTNXdFeldWaFFzT3BhaGdtbllGZnVLbWFTUWtjMjdrU0tUMFZBNEI1SlNqTVE4M2VoQ0FVSUVwaWZXdFJnd0xoTzNPWE9iVUN0cEJvT2huVGVXUk9VaHN2dl9YUFBfZm1Pelk1TFhIMDZPd3YxbzZhdW10eVVBTlBR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxOcFNTNXdFeldWaFFzT3BhaGdtbllGZnVLbWFTUWtjMjdrU0tUMFZBNEI1SlNqTVE4M2VoQ0FVSUVwaWZXdFJnd0xoTzNPWE9iVUN0cEJvT2huVGVXUk9VaHN2dl9YUFBfZm1Pelk1TFhIMDZPd3YxbzZhdW10eVVBTlBR?oc=5\" target=\"_blank\">Should You Buy Vertex Pharmaceuticals Before Feb. 12?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2026-02-09T19:06:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Vertex Gears Up to Report Q4 Earnings: Is a Beat in the Cards? - TradingView",
      "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQcFhYNGJEQ1ozTHFzZXJGcFEtVGVCakdPbGJzSDJ2ejRGZE9xLUlPZ2hNV0NsMDdwMk1tRmdfZ0xab1lWTW01cVJfU2F0MzFJVkJtc28yWXY4ckJBQTB3ZHlka1ZsWEFkckZneFRKWXMwOUU3RFFPRVlEZjFRcjdtdTFiMU5fZ29IbjhDbmxid19reGFHZFhmZ0lCczV1SkZTMUhSVFdXdlJqanExajdKUldXR3JIczA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxQcFhYNGJEQ1ozTHFzZXJGcFEtVGVCakdPbGJzSDJ2ejRGZE9xLUlPZ2hNV0NsMDdwMk1tRmdfZ0xab1lWTW01cVJfU2F0MzFJVkJtc28yWXY4ckJBQTB3ZHlka1ZsWEFkckZneFRKWXMwOUU3RFFPRVlEZjFRcjdtdTFiMU5fZ29IbjhDbmxid19reGFHZFhmZ0lCczV1SkZTMUhSVFdXdlJqanExajdKUldXR3JIczA?oc=5\" target=\"_blank\">Vertex Gears Up to Report Q4 Earnings: Is a Beat in the Cards?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2026-02-10T15:45:00+00:00",
      "source": "TradingView"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-02-10",
      "close": 463.4800109863281
    },
    "history": [
      {
        "date": "2026-02-02",
        "close": 472.010009765625
      },
      {
        "date": "2026-02-03",
        "close": 465.6099853515625
      },
      {
        "date": "2026-02-04",
        "close": 470.5199890136719
      },
      {
        "date": "2026-02-05",
        "close": 458.80999755859375
      },
      {
        "date": "2026-02-06",
        "close": 477.9200134277344
      },
      {
        "date": "2026-02-09",
        "close": 470.8699951171875
      },
      {
        "date": "2026-02-10",
        "close": 463.4800109863281
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}